Designing the matrix: extracellular matrix-informed strategies for bioengineered cancer models
Frontiers in Bioengineering and Biotechnology · 24.08.2026 · 14
DOI: 10.3389/fbioe.2026.1894741 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 24.08.2026. Verfasst von Nathalie Bock und 6 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Queensland Centre for the Materials Science of Extracellular Matrices (MPQC), Brisbane, QLD, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kids’ Cancer Project, National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
Bioengineered three-dimensional (3D) cancer models have improved the replication of tumour architecture and microenvironmental complexity, yet their predictive value and reproducibility remain inconsistent. A key reason is that extracellular matrix (ECM) context is often treated as a background culture condition rather than as an explicit experimental variable. Cancer cells respond not only to dimensionality, but also to coupled biochemical, structural, mechanical and dynamic matrix cues, including ligand presentation, fibre architecture, porosity, stiffness, viscoelasticity, degradability and remodelling. In this mini-review, we examine ECM-mimicking cancer models through a materials science-informed lens and argue that matrix selection should be guided by model purpose rather than perceived physiological complexity alone. We discuss tissue-derived matrices for preserving tissue-specific and patient-relevant cues, natural and semi-synthetic hydrogels for balancing biological context with usability, synthetic matrices for mechanistic dissection, transport-aware systems for drug-response studies and dynamic hydrogels for modelling time-dependent matrix remodelling. We propose that ECM mimicry should move from a descriptive label to a hypothesis-driven design principle. Making matrix design explicit will improve comparison across models, reduce ambiguity in interpreting cancer phenotypes and strengthen the mechanistic and translational relevance of in vitro cancer systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Max Planck Queensland Centre for the Materials Science of Extracellular Matrices (MPQC), Brisbane, QLD, Australia.
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT) at the Translational Research Institute (TRI), Centre for Biomedical Technologies (CBT), Woolloongabba, QLD, Australia.
- Gelomics Pty Ltd., Brisbane, QLD, Australia.
- ARC Training Centre for Cell and Tissue Engineering Technologies, QUT, Brisbane, QLD, Australia.
Förderung
- Kids’ Cancer Project
- National Health and Medical Research Council
- Australian Research Council
- Tour de Cure
Zitieren
APA
Bock, N., Koikalethu, A. T., Hipwood, L., Dekker, M., Lundon, B., Bhatia, S., & McGovern, J. A. (2026). Designing the matrix: extracellular matrix-informed strategies for bioengineered cancer models. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1894741
Vancouver
Bock N, Koikalethu AT, Hipwood L, Dekker M, Lundon B, Bhatia S, et al. Designing the matrix: extracellular matrix-informed strategies for bioengineered cancer models. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1894741
BibTeX
@article{Bock2026,
author = {Bock, Nathalie and Koikalethu, Anu Thomas and Hipwood, Luke and Dekker, Minne and Lundon, Brooke and Bhatia, Sugandha and McGovern, Jacqui A},
title = {Designing the matrix: extracellular matrix-informed strategies for bioengineered cancer models},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1894741}
}
EUVIMED